molecular profiling Natera Revenues Grow 35 Percent in Q4 The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million. 4HF Biotec Banking on Multiomic Data Analysis to Help Pharma Find New Oncology Compounds Premium German bioinformatics startup 4HF Biotec targets early-stage biotech development with technology to predict drug sensitivity based on tumor genetic profiles. Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition The new consortium is aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the US, to help inform their treatment decisions. BostonGene, Thomas Jefferson University Partner on Head, Neck Cancer Research The partners will apply whole-exome and whole-transcriptome analysis to evaluate two existing drugs for squamous cell carcinoma treatment. PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis PierianDx will integrate its cancer profiling assays with Pillar Biosciences' PiVAT bioinformatics pipeline on a GPDR-compliant platform. Jun 15, 2020 Roswell Biotechnologies Enters Critical Phase of Industrializing Molecular Sensor Production Premium Jun 2, 2020 Evidence for Targeted Treatment Builds in Cancers of Unknown Primary but Randomized Data Pending Premium May 27, 2020 John Theurer Cancer Center, Genomic Testing Cooperative to Establish NGS Lab for Cancers May 6, 2020 Pediatric Cancer Patients With Solid Tumors Have Many Druggable Germline Alterations Nov 12, 2019 HTG Molecular Diagnostics Revenues Grow 15 Percent; Firm Lowers Full-Year Guidance Jul 30, 2019 Illumina Says Population Sequencing, DTC Will Continue to Grow in the Long Term Premium Jul 23, 2019 BostonGene Partners With NIH on Clonal Evolution Study Jul 12, 2019 Pathologists Face Hurdles in Supporting Precision Oncology, Seek Shared Decision Making Premium Apr 26, 2019 Inivata Clinical Validation Bolsters Liquid Biopsy Evidence Base, Aids Platform Comparisons Premium Apr 25, 2019 Precision Cancer Software Startup BostonGene Lands $50M in Series A Round Oct 1, 2018 Caris Raises $150M in Debt, Convertible Note Financing Jun 19, 2018 Roche to Acquire Outstanding Shares of Foundation Medicine for $2.4B Apr 26, 2018 FDA Grants Breakthrough Device Designation to Foundation Medicine Liquid Biopsy Assay Jan 31, 2018 Syapse Expands Into Asia With Korean Hospital Deal Jan 30, 2018 Foundation Medicine to Profile Samples for European Cancer Network to Aid Clinical Trial Enrollment Dec 4, 2017 UCSF, NantHealth Team on Metastatic Breast Cancer Study Nov 15, 2017 FDA Approves MSKCC Tumor Profiling Test; Accredits NY State Health Department as IVD Reviewer Nov 8, 2017 Caris Life Sciences Sues Foundation Medicine, Alleging Patent Infringement Sep 20, 2017 Hearst Invests $75M in M2Gen Jun 15, 2017 Small-Bowel Adenocarcinoma Is Molecularly Distinct From Colorectal, Gastric Cancers Load More Breaking News Lunaphore Technologies, University of Bern Partner on Colorectal Cancer Study People in the News: New Appointments at Biocept, Novacyt, Centogene, Illumina, More In Brief This Week: Sophia Genetics, Twist Bioscience, Dante Labs, MGI, Codex DNA, More New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The Scan Interfering With Invasive Mussels The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels. Participation Analysis A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports. Right Whales' Decline A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC. Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.